ATLANTA, GA -- (MARKET WIRE) -- April 16, 2007 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it will release its first quarter 2007 financial results on Thursday, April 26, 2007, before the U.S. financial markets open.
